Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Obesity Studies

Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis

  1. Chiara Ruocco1,
  2. Maurizio Ragni1,
  3. Fabio Rossi1,
  4. Pierluigi Carullo2,3,
  5. Veronica Ghini4,
  6. Fabiana Piscitelli5,
  7. Adele Cutignano5,
  8. Emiliano Manzo5,
  9. Rafael Maciel Ioris6,7,
  10. Franck Bontems6,7,
  11. Laura Tedesco1,
  12. Carolina M. Greco2,
  13. Annachiara Pino8,
  14. Ilenia Severi9,
  15. Dianxin Liu10,
  16. Ryan P. Ceddia10,
  17. Luisa Ponzoni1,11,
  18. Leonardo Tenori12,13,
  19. Lisa Rizzetto14,
  20. Matthias Scholz14,
  21. Kieran Tuohy14,
  22. Francesco Bifari15,
  23. Vincenzo Di Marzo16,17,
  24. Claudio Luchinat4,18,
  25. Michele O. Carruba1,
  26. Saverio Cinti9,
  27. Ilaria Decimo8,
  28. Gianluigi Condorelli2,3,19,
  29. Roberto Coppari6,7,
  30. Sheila Collins10,
  31. Alessandra Valerio20 and
  32. Enzo Nisoli1⇑
  1. 1Center for Study and Research on Obesity, Department of Biomedical Technology and Translational Medicine, University of Milan, Milan, Italy
  2. 2IRCCS Humanitas Clinical and Research Center, Rozzano, Italy
  3. 3Institute of Genetic and Biomedical Research, National Research Council, Rozzano, Italy
  4. 4Interuniversity Consortium for Magnetic Resonance, Sesto Fiorentino, Italy
  5. 5Institute of Biomolecular Chemistry, National Research Council, Pozzuoli, Italy
  6. 6Department of Cell Physiology and Metabolism, University of Geneva, Geneva, Switzerland
  7. 7Diabetes Center of the Faculty of Medicine, University of Geneva, Geneva, Switzerland
  8. 8Department of Diagnostics and Public Health, University of Verona, Verona, Italy
  9. 9Department of Experimental and Clinical Medicine, Marche Polytechnic University, Center of Obesity, Ancona, Italy
  10. 10Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
  11. 11Institute of Neuroscience, National Research Council, Milan, Italy
  12. 12FiorGen Foundation, Sesto Fiorentino, Italy
  13. 13Center of Magnetic Resonance, University of Florence, Sesto Fiorentino, Italy
  14. 14Department of Food Quality and Nutrition, Research and Innovation Center, Edmund Mach Foundation, San Michele all’Adige, Italy
  15. 15Laboratory of Cell Metabolism and Regenerative Medicine, Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
  16. 16Canada Excellence Research Chair Microbiome-Endocannabinoidome Axis in Metabolic Health, Université Laval, Quebec City, Canada
  17. 17Joint International Research Unit for Chemical and Biochemical Research on the Microbiome and Its Impact on Metabolic Health and Nutrition, Institute of Biomolecular Chemistry, National Research Council, Pozzuoli, Italy and Université Laval, Quebec City, Canada
  18. 18Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
  19. 19Humanitas University, Rozzano, Italy
  20. 20Department of Molecular and Translational Medicine, Brescia University, Brescia, Italy
  1. Corresponding author: Enzo Nisoli, enzo.nisoli{at}unimi.it
  1. C.R. and M.R. contributed equally to this work.

Diabetes 2020 Nov; 69(11): 2324-2339. https://doi.org/10.2337/db20-0489
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    EAA, unlike CAA substitution for protein content of rodent diets, prevents and reverses obesity, with the improvement of glucose homeostasis and extension of average life span. A: Body weight of mice fed with the chow, SFA, SFA-EAA, and SFA-CAA diet at room temperature (n = 7–10 mice per group). After maximal body weight was reached (11 months, dashed line), mice fed with the SFA diet were switched to either the SFA-EAA diet (SFA to SFA-EAA) or the SFA-CAA diet (SFA to SFA-CAA) (n = 5 mice per group). B: Body weight of mice at room temperature (n = 9–10 mice per group). C: Body composition at the end of treatment: fat mass (left) and lean mass (right) (n = 6 mice per group). D: Plasma leptin levels at different times at room temperature (n = 5 mice per group). E: Body weight of mice at thermoneutrality (30°C) (n = 10 mice per group). Glucose tolerance test results in mice at room temperature (n = 5 mice per group) (F) or at thermoneutrality (G) (n = 7 mice per group). Mice were fed with different diets for 6 weeks. Plasma levels of adiponectin (H) and IGF-1 (I) in mice fed with the SFA-CAA or SFA-EAA diet for 6 weeks at room temperature (n = 5 mice per group). J: Kaplan-Meier survival curves for chow, SFA-, SFA-EAA–, and SFA-CAA–fed mice (n = 35 mice per group). All data (except J) are presented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. SFA diet; #P < 0.05, ##P < 0.01, and ###P < 0.001 vs. SFA-CAA diet; §P < 0.05, §§P < 0.01, and §§§P < 0.001 vs. chow diet.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Food intake and energy absorption in mice on different dietary regimens. A: Food intake of mice fed with chow, SFA, SFA-EAA, and SFA-CAA diets for different time intervals (n = 5–7 mice per group). B: Gut transit time. C: Hematoxylin and eosin staining of jejunum villi. Scale bar, 90 μm. D: Energy excretion: the mean amount of feces excreted per mouse in 24 h (mg/24 h) (left) and food excreted (dry mass of fecal pellets, collected over 72 h and expressed as the percentage of food intake) (right). E: Mean energy content in feces (kcal/g). F: Daily energy excretion (kcal/mouse) calculated using the previous values (n = 3–5 mice per group). B–F: Mice were fed with the SFA, SFA-CAA, and SFA-EAA diets for 6 weeks. All data are presented as mean ± SEM. **P < 0.01 and ***P < 0.001 vs. SFA diet; ###P < 0.001 vs. SFA-CAA; §§§P < 0.001 vs. chow diet.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Energy metabolism in mice on different dietary regimens. A: Metabolic efficiency was calculated as the body weight (BW) gain-to-the energy intake ratio (i.e., total food consumed during 5 days or 2 or 6 weeks). EE (B) and RER (C) during one 24-h cycle. D: Whole-body temperature measured with a digital rectal thermometer. Measurements were performed in two separate experiments after 2 or 6 weeks (n = 5–7 mice per group). All data are presented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. SFA-CAA diet.

  • Figure 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4

    SFA-EAA diet changes gut microbiota composition. A: Chao index, Shannon entropy index, and α-diversity calculated on the number of observed operational taxonomic units (OTUs). B: Principal coordinates analysis (PCoA) of bacterial β-diversity based on the Bray-Curtis dissimilarity index. Each symbol represents a single sample of feces after 6 weeks of treatment. C: Box-and-whisker plot of intercommunity β-diversity determined by the Bray-Curtis dissimilarity index. D: Phylum/order level relative abundance expressed as geometric mean. E: Allobaculum, Sutterella, and Lactococcus relative abundance. F: Random forest analysis. For the box-and-whisker plots, the boxes show median and first and third quartiles. The whiskers extend from the quartiles to the last data point within 1.5× interquartile range, with outliers beyond represented as dots (n = 10 mice per group). *P < 0.05, **P < 0.01, and ***P < 0.001 as shown.

  • Figure 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5

    The SFA-EAA diet promotes uncoupled respiration in iWAT without browning stimulation. A: Uncoupled (i.e., with oligomycin) and maximal (i.e., with FCCP) OCRs in iWAT mitochondria; respiration was normalized to mitochondrial protein amount (n = 5 mice per group). B: Western blot analysis of UCP1 and HSP60 protein levels in adipose tissues (n = 4 mice per group). One experiment representative of three reproducible ones is shown. iBAT of mice fed with the chow diet at room temperature was used as the control. C: Thermogenic N-acyl amino acids in plasma (left) and iWAT (right) (n = 4–5 mice per group). D: Relative mRNA levels of the Pm20d1 gene in different tissues (n = 5 mice per group). A–D: Mice were fed with the SFA-CAA and SFA-EAA diet for 6 weeks at thermoneutrality. All data are presented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. SFA-CAA diet.

  • Figure 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6

    SFA-EAA diet increases the thermogenic function of iBAT. A: iBAT temperature was measured with a thermographic FLIR camera in mice fed with the SFA-CAA and SFA-EAA diet for 6 weeks at room temperature (n = 5 mice per group). B: Uncoupled (i.e., ΔGDP, UCP1-dependent respiration calculated as the amount of ADP-independent respiration that was inhibited by GDP) and maximal (FCCP) OCRs in iBAT mitochondria; respiration was normalized to mitochondrial protein amount (n = 5 mice per group). C: Western blot analysis of UCP1 and GAPDH protein levels in iBAT. One experiment representative of three reproducible ones is shown (n = 3–5 mice per group). Mice in B and C were fed with the SFA-CAA and SFA-EAA diet for 1, 5, or 20 days at room temperature. D: Uncoupled (ΔGDP) and maximal (FCCP) OCR in iBAT mitochondria (n = 6 mice per group). E: Western blot analysis of UCP1, cytochrome c oxidase subunit IV (COX IV), cytochrome c (Cyt c), and GAPDH protein levels in iBAT. One experiment representative of three reproducible ones is shown (n = 4 mice per group). F: Electron microscopy analysis of iBAT. Scale bar, 0.5 μm (n = 2 mice per group). Mice in D–F were fed with the SFA-CAA and SFA-EAA diet for 6 weeks at room temperature. All data are presented as mean ± SEM. *P < 0.05 and **P < 0.01 vs. SFA-CAA diet.

  • Figure 7
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7

    The SFA-EAA diet activates brown adipocytes. A: NE turnover (NETO) in iBAT of mice fed with the SFA-CAA and SFA-EAA diet for 6 weeks at room temperature. NETO was assessed by NE synthesis inhibition with α-methyl-p-tyrosine (n = 5 mice per group). B: Relative mRNA levels of noradrenergic innervation markers in iBAT of mice fed with the SFA-CAA and SFA-EAA diet for 6 weeks. C: Scheme of the in vitro experiment in primary brown adipocytes isolated from mice fed with the chow diet. After 16-h incubation in amino acid-free medium, brown adipocytes were pretreated with rapamycin (Rapa, 1.0 nmol/L) or vehicle (Veh; DMSO) for 1 h. Then, the cells were supplemented with Veh (PBS) or CAA mixture (CAAm) or EAA mixture (EAAm), specifically reproducing the iBAT aminograms resulting from consumption of either the SFA-CAA or SFA-EAA diets, respectively, as reported in Supplementary Table 4 (n = 3 experiments performed in triplicate). D: Ucp1 mRNA levels in differentiated brown adipocytes, treated as in C. Western blot analysis of UCP1 and GAPDH (E), and (Ser 235/236) phosphorylated (p) S6 and S6 (G) protein levels in differentiated brown adipocytes, treated as in C. One immunoblot experiment representative of three reproducible ones is shown. F: OCRs of differentiated brown adipocytes, treated as in C. OCR was measured with the Seahorse XF24 Extracellular Flux Analyzer (n = 3 readings in quadruplicate per group). All data are presented as mean ± SEM. **P < 0.01 and ***P < 0.001 vs. Veh; #P < 0.05, ##P < 0.01, and ###P < 0.001 vs. CAAm; §P < 0.05 and §§§P < 0.001 vs. EAAm + Rapa. TH, tyrosine hydroxylase; β3AR, β3-adrenergic receptor.

  • Figure 8
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8

    mTORC1 signaling contributes to iBAT thermogenesis induced by the SFA-EAA diet. A: Western blot analysis of (Ser 235/236) phosphorylated (p) S6 and S6 protein levels in iBAT of mice fed with the SFA-CAA and SFA-EAA diet for different time intervals at room temperature. One immunoblot experiment representative of three reproducible ones is shown (n = 3–5 mice per group). B: Western blot analysis of the mTORC1 pathway in iBAT of mice fed with the SFA-CAA and SFA-EAA diet, with vehicle (Veh) or rapamycin (Rapa) (n = 4 mice per group). C: UCP1-dependent (ΔGDP) and maximal (FCCP) OCRs in iBAT mitochondria. OCR was normalized to mitochondrial protein amount (n = 5 mice per group). D: Rectal and thermographic measurement of iBAT temperature (n = 5 mice per group). E: Western blot analysis of UCP1 protein levels in iBAT. Mice in B–E were fed with the SFA-CAA or SFA-EAA diet for 6 weeks at room temperature, with or without rapamycin (i.p. 2.5 mg/kg body wt) delivered in 200 μL, 5 days per week for 6 weeks, starting with diets (n = 5–6 mice per group). All data are presented as mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. SFA-CAA diet; #P < 0.05 vs. SFA-EAA diet. 4E-BP1, eukaryotic initiation factor 4E-binding protein 1.

PreviousNext
Back to top
Diabetes: 69 (11)

In this Issue

November 2020, 69(11)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis
Chiara Ruocco, Maurizio Ragni, Fabio Rossi, Pierluigi Carullo, Veronica Ghini, Fabiana Piscitelli, Adele Cutignano, Emiliano Manzo, Rafael Maciel Ioris, Franck Bontems, Laura Tedesco, Carolina M. Greco, Annachiara Pino, Ilenia Severi, Dianxin Liu, Ryan P. Ceddia, Luisa Ponzoni, Leonardo Tenori, Lisa Rizzetto, Matthias Scholz, Kieran Tuohy, Francesco Bifari, Vincenzo Di Marzo, Claudio Luchinat, Michele O. Carruba, Saverio Cinti, Ilaria Decimo, Gianluigi Condorelli, Roberto Coppari, Sheila Collins, Alessandra Valerio, Enzo Nisoli
Diabetes Nov 2020, 69 (11) 2324-2339; DOI: 10.2337/db20-0489

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Manipulation of Dietary Amino Acids Prevents and Reverses Obesity in Mice Through Multiple Mechanisms That Modulate Energy Homeostasis
Chiara Ruocco, Maurizio Ragni, Fabio Rossi, Pierluigi Carullo, Veronica Ghini, Fabiana Piscitelli, Adele Cutignano, Emiliano Manzo, Rafael Maciel Ioris, Franck Bontems, Laura Tedesco, Carolina M. Greco, Annachiara Pino, Ilenia Severi, Dianxin Liu, Ryan P. Ceddia, Luisa Ponzoni, Leonardo Tenori, Lisa Rizzetto, Matthias Scholz, Kieran Tuohy, Francesco Bifari, Vincenzo Di Marzo, Claudio Luchinat, Michele O. Carruba, Saverio Cinti, Ilaria Decimo, Gianluigi Condorelli, Roberto Coppari, Sheila Collins, Alessandra Valerio, Enzo Nisoli
Diabetes Nov 2020, 69 (11) 2324-2339; DOI: 10.2337/db20-0489
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Discussion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Deletion of the Brain-Specific α and δ Isoforms of Adapter Protein SH2B1 Protects Mice From Obesity
  • CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
  • Glucose Sensing Mediated by Portal Glucagon-Like Peptide 1 Receptor Is Markedly Impaired in Insulin-Resistant Obese Animals
Show more Obesity Studies

Similar Articles

Subjects

  • Obesity-Animal

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.